Inhibitors of Monoamine Oxidase and Acetylcholinesterase as a Front Runner in CNS Drug Discovery

Comb Chem High Throughput Screen. 2020;23(9):834-835. doi: 10.2174/138620732309201127093123.

Authors

Bijo Mathew¹, Hoon Kim²

Affiliations

¹ Department of Pharmaceutical Chemistry Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Amrita Health Science Campus, Kochi-682 041, India.
² Department of Pharmacy Sunchon National University Suncheon 57922, Korea.

PMID: 33357175
DOI: 10.2174/138620732309201127093123

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Acetylcholinesterase / metabolism*
Anxiety Disorders / drug therapy
Anxiety Disorders / prevention & control
Biological Products / chemistry
Biological Products / metabolism
Depression / drug therapy
Depression / prevention & control
Drug Discovery
Enzyme Inhibitors / chemistry*
Enzyme Inhibitors / metabolism
Humans
Monoamine Oxidase / metabolism*
Secondary Metabolism

Substances

Biological Products
Enzyme Inhibitors
Monoamine Oxidase
Acetylcholinesterase